Oncology

CD40-antibody drugs could have enhanced anti-tumor activity.

Drug efficacy varies in colorectal cancer dependent on where the tumor is located.

Certain bacterial populations are increased or decreased in the presence of cancer.

After breast cancer surgery, patients who received non-opiate analgesia used less painkilling medication than patients who received opiate analgesia.

A majority of patients with specific gene mutation will eventually relapse and die of treatment-resistant leukemia.

Genetic changes to BRCA1 predicts higher risk of breast and ovarian cancers.

Treating modifiable risk factors could enhance breast cancer prevention.

Anti-nausea and vomit medication could help reduce hospitalization in liver cancer.

Recent advances and updates in oncology and cancer drug development.

MEDI4736 is an experimental human monoclonal antibody used against PDL1.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Cystatin E/M stops inflammation that cervical cancer cells need to grow.

Breast cancer cells found to hide in bone marrow before resurging.

Pancreatic cancer patients whose tumors surround critical blood vessels may have new treatment options.

Immunotherapy for lung cancer patients may cause other conditions to become worse.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Vitamin A combined with Gemzar found to reduce proliferation of cancer cells.

Researchers still urge physicians to use caution utilizing light phototherapy for jaundice infants.

Xilonix is the first monoclonal antibody immunotherapy that targets and neutralizes interleukin-1 alpha.

Malignant brain tumor cells found to rely on fats for energy and growth.

Radiation therapy with checkpoint inhibitors offers promise for skin cancer therapy.

Top news of the day from across the health care landscape.

Researchers were able to better predict the risk of developing breast cancer.

System provides images deep within tumor tissue.

On February 17, 2017, a pharmacist will be climbing Mount Kilimanjaro to support the Multiple Myeloma Research Foundation.

Concern persists among physicians who treat HIV-associated lymphoma with stem cell transplants due to the risk of harming the immune system.